Effectiveness and Safety of Linezolid Versus Vancomycin, Teicoplanin, or Daptomycin against Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia: A Systematic Review and Meta-Analysis
Vancomycin (VCM) and daptomycin (DAP) are standard therapies for methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) bacteremia, despite concerns regarding clinical utility and growing resistance. Linezolid (LZD) affords superior tissue penetration to VCM or DAP and has been successfully used...
Gorde:
| Egile Nagusiak: | , , , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
MDPI AG
2023-04-01
|
| Saila: | Antibiotics |
| Gaiak: | |
| Sarrera elektronikoa: | https://www.mdpi.com/2079-6382/12/4/697 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|
